Literature DB >> 33627107

Liquid biopsy proteomics of uveal melanoma reveals biomarkers associated with metastatic risk.

Gabriel Velez1,2,3, Huy V Nguyen2, Teja Chemudupati1,2, Cassie A Ludwig2, Marcus Toral1,2,3, Sunil Reddy4, Prithvi Mruthyunjaya2, Vinit B Mahajan5,6,7.   

Abstract

Entities:  

Keywords:  Biomarker; Cancer; HGFR; Liquid biopsy; Proteomics; SCFR; STAT3; Uveal melanoma; Vitreous

Year:  2021        PMID： 33627107      PMCID： PMC7903662          DOI： 10.1186/s12943-021-01336-4

Source DB:  PubMed          Journal:  Mol Cancer        ISSN： 1476-4598            Impact factor:   27.401


× No keyword cloud information.
  11 in total

Review 1.  MOLECULAR PROGNOSTICS FOR UVEAL MELANOMA.

Authors:  Michael I Seider; Prithvi Mruthyunjaya
Journal:  Retina       Date:  2018-02       Impact factor: 4.256

2.  Gene Expression Profiling and PRAME Status Versus Tumor-Node-Metastasis Staging for Prognostication in Uveal Melanoma.

Authors:  Louis Cai; Manuel Paez-Escamilla; Scott D Walter; Bercin Tarlan; Christina L Decatur; Barbara M Perez; J William Harbour
Journal:  Am J Ophthalmol       Date:  2018-08-06       Impact factor: 5.258

Review 3.  Uveal melanoma: trends in incidence, treatment, and survival.

Authors:  Arun D Singh; Mary E Turell; Allan K Topham
Journal:  Ophthalmology       Date:  2011-06-24       Impact factor: 12.079

4.  Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).

Authors:  M J Hendrix; E A Seftor; R E Seftor; D A Kirschmann; L M Gardner; H C Boldt; M Meyer; J Pe'er; R Folberg
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

5.  Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma.

Authors:  Michael D Onken; Lori A Worley; Devron H Char; James J Augsburger; Zelia M Correa; Eric Nudleman; Thomas M Aaberg; Michael M Altaweel; David S Bardenstein; Paul T Finger; Brenda L Gallie; George J Harocopos; Peter G Hovland; Hugh D McGowan; Tatyana Milman; Prithvi Mruthyunjaya; E Rand Simpson; Morton E Smith; David J Wilson; William J Wirostko; J William Harbour
Journal:  Ophthalmology       Date:  2012-04-21       Impact factor: 12.079

6.  An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma.

Authors:  Michael D Onken; Lori A Worley; Meghan D Tuscan; J William Harbour
Journal:  J Mol Diagn       Date:  2010-04-22       Impact factor: 5.568

7.  PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma.

Authors:  Matthew G Field; Christina L Decatur; Stefan Kurtenbach; Gülçin Gezgin; Pieter A van der Velden; Martine J Jager; Kaleigh N Kozak; J William Harbour
Journal:  Clin Cancer Res       Date:  2016-03-01       Impact factor: 12.531

8.  Phase II randomised discontinuation trial of the MET/VEGF receptor inhibitor cabozantinib in metastatic melanoma.

Authors:  Adil Daud; Harriet M Kluger; Razelle Kurzrock; Frauke Schimmoller; Aaron L Weitzman; Thomas A Samuel; Ali H Moussa; Michael S Gordon; Geoffrey I Shapiro
Journal:  Br J Cancer       Date:  2017-01-19       Impact factor: 7.640

9.  Personalized Proteomics for Precision Health: Identifying Biomarkers of Vitreoretinal Disease.

Authors:  Gabriel Velez; Peter H Tang; Thiago Cabral; Galaxy Y Cho; Daniel A Machlab; Stephen H Tsang; Alexander G Bassuk; Vinit B Mahajan
Journal:  Transl Vis Sci Technol       Date:  2018-09-26       Impact factor: 3.283

10.  Single-cell analysis reveals new evolutionary complexity in uveal melanoma.

Authors:  Michael A Durante; Daniel A Rodriguez; Stefan Kurtenbach; Jeffim N Kuznetsov; Margaret I Sanchez; Christina L Decatur; Helen Snyder; Lynn G Feun; Alan S Livingstone; J William Harbour
Journal:  Nat Commun       Date:  2020-01-24       Impact factor: 14.919
View more
  3 in total

Review 1.  Proteomics in uveal melanoma.

Authors:  Michael J Heiferman; Vinit B Mahajan; Prithvi Mruthyunjaya
Journal:  Curr Opin Ophthalmol       Date:  2022-01-31       Impact factor: 4.299

Review 2.  Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions.

Authors:  Nuno Jorge Lamas; Arnaud Martel; Sacha Nahon-Estève; Samantha Goffinet; Adam Macocco; Corine Bertolotto; Sandra Lassalle; Paul Hofman
Journal:  Cancers (Basel)       Date:  2021-12-25       Impact factor: 6.639

Review 3.  Intraocular fluid biomarkers (liquid biopsy) in human diabetic retinopathy.

Authors:  Edoardo Midena; Luisa Frizziero; Giulia Midena; Elisabetta Pilotto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-07-03       Impact factor: 3.117
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.